Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and raloxifene hydrochloride

17 alpha-hydroxyprogesterone caproate has been researched along with raloxifene hydrochloride in 1 studies

Compound Research Comparison

Studies
(17 alpha-hydroxyprogesterone caproate)
Trials
(17 alpha-hydroxyprogesterone caproate)
Recent Studies (post-2010)
(17 alpha-hydroxyprogesterone caproate)
Studies
(raloxifene hydrochloride)
Trials
(raloxifene hydrochloride)
Recent Studies (post-2010) (raloxifene hydrochloride)
517882512,818481810

Protein Interaction Comparison

ProteinTaxonomy17 alpha-hydroxyprogesterone caproate (IC50)raloxifene hydrochloride (IC50)
Estrogen receptorHomo sapiens (human)0.0053
Gastric inhibitory polypeptide receptorHomo sapiens (human)0.0004
Estrogen receptor betaHomo sapiens (human)0.1297

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izutsu, T; Sugiyama, T1

Reviews

1 review(s) available for 17 alpha-hydroxyprogesterone caproate and raloxifene hydrochloride

ArticleYear
[Hormone therapy for uterine corpus cancer--introduction].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome

2004